4552

JP:CO:JCRPHARM

JCRファーマ株式会社

  • Stock

Last Close

666.00

25/09 06:15

Market Cap

77.50B

Beta: -

Volume Today

755.60K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
5.05B
-
5.75B
13.98%
6.87B
19.44%
7.54B
9.72%
8.38B
11.14%
9.07B
8.23%
8.99B
0.93%
11.20B
24.69%
14.10B
25.80%
16.57B
17.59%
average payables
716.35M
-
615.53M
14.07%
658.69M
7.01%
741.83M
12.62%
642.64M
13.37%
585.50M
8.89%
632.50M
8.03%
1.81B
185.45%
2.13B
17.86%
1.44B
32.17%
average receivables
5.01B
-
5.09B
1.72%
5.81B
14.02%
5.91B
1.75%
6.71B
13.58%
8.22B
22.42%
8.41B
2.30%
8.08B
3.88%
11.88B
47.08%
13.36B
12.43%
book value per share
193.39
-
206.27
6.66%
212.17
2.86%
218.20
2.84%
219.81
0.74%
249.17
13.36%
262.72
5.44%
310.72
18.27%
411.26
32.36%
419.61
2.03%
capex per share
-18.96
-
-10.53
44.48%
-11.09
5.32%
-12.27
10.65%
-8.03
34.52%
-7.27
9.50%
-39.24
439.91%
-60.94
55.29%
-91.60
50.32%
-68.86
24.83%
capex to depreciation
-2.17
-
-0.99
54.26%
-1.00
1.35%
-1.07
6.64%
-0.72
32.52%
-0.67
7.81%
-3.37
406.26%
-3.98
17.92%
-5.83
46.46%
-4.29
26.44%
capex to operating cash flow
-0.53
-
-2.69
408.84%
-0.64
76.09%
-0.58
8.93%
-0.32
45.48%
-0.23
28.12%
-0.98
328.43%
-0.73
25.87%
-1.22
67.62%
1.56
227.57%
capex to revenue
-0.15
-
-0.08
48.17%
-0.08
1.97%
-0.09
5.74%
-0.05
43.42%
-0.04
20.34%
-0.20
405.20%
-0.25
28.15%
-0.22
11.32%
-0.25
12.35%
cash per share
57.00
-
38.27
32.85%
30.39
20.61%
45.96
51.25%
49.14
6.92%
69.00
40.44%
90.79
31.57%
210.78
132.16%
250.38
18.79%
105.09
58.03%
days of inventory on hand
318.97
-
407.00
27.60%
414.92
1.95%
492.74
18.76%
537.43
9.07%
506.73
5.71%
409.07
19.27%
633.28
54.81%
510.67
19.36%
760.48
48.92%
days payables outstanding
43.55
-
33.95
22.04%
44.27
30.38%
44.59
0.74%
34.84
21.86%
32.57
6.53%
31.37
3.69%
136.99
336.73%
46.20
66.28%
64.20
38.98%
days sales outstanding
106.11
-
121.72
14.72%
125.47
3.08%
117.56
6.30%
134.68
14.56%
139.24
3.38%
117.49
15.62%
99.28
15.50%
111.36
12.17%
118.36
6.29%
debt to assets
0.13
-
0.11
16.15%
0.09
15.34%
0.13
47.19%
0.15
13.66%
0.13
10.82%
0.18
35.98%
0.25
33.83%
0.19
24.04%
0.24
28.88%
debt to equity
0.17
-
0.14
20.07%
0.12
14.80%
0.18
48.64%
0.21
21.01%
0.19
12.01%
0.27
44.75%
0.47
74.43%
0.36
24.57%
0.44
22.88%
dividend yield
0.01
-
0.01
35.20%
0.01
5.79%
0.01
14.39%
0.00
55.78%
0.00
7.50%
0.00
20.03%
0.00
28.20%
0.01
217.60%
0.02
100.75%
earnings yield
0.02
-
0.02
22.19%
0.02
4.16%
0.02
9.01%
0.02
31.88%
0.02
16.67%
0.01
51.39%
0.02
68.74%
0.05
233.79%
0.02
58.66%
enterprise value
78.52B
-
82.50B
5.06%
82.94B
0.54%
77.36B
6.73%
189.67B
145.17%
193.68B
2.12%
288.12B
48.76%
434.65B
50.86%
266.60B
38.66%
185.17B
30.55%
enterprise value over ebitda
27.68
-
23.00
16.91%
22.24
3.32%
19.61
11.83%
36.36
85.45%
30.21
16.92%
60.67
100.82%
41.55
31.52%
11.85
71.48%
24.76
108.96%
ev to operating cash flow
17.20
-
165.31
861.13%
37.67
77.21%
29.18
22.54%
60.54
107.48%
49.60
18.07%
58.48
17.90%
42.03
28.12%
28.70
31.72%
-33.67
217.30%
ev to sales
5.00
-
4.89
2.10%
4.76
2.82%
4.28
10.06%
9.21
115.30%
8.36
9.20%
11.63
39.03%
14.45
24.26%
5.22
63.87%
5.39
3.31%
free cash flow per share
16.96
-
-6.61
138.95%
6.18
193.49%
8.71
40.97%
17.16
97.03%
24.44
42.48%
0.72
97.05%
22.78
3,055.81%
-16.52
172.52%
-113.11
584.62%
free cash flow yield
0.03
-
-0.01
136.74%
0.01
191.70%
0.01
46.28%
0.01
19.86%
0.02
35.99%
0.00
98.01%
0.01
1,973.06%
-0.01
215.19%
-0.08
993.55%
graham net net
34.13
-
35.10
2.84%
29.47
16.03%
41.51
40.87%
43.83
5.57%
65.27
48.92%
51.96
20.38%
30.10
42.07%
31.81
5.68%
-95.34
399.70%
graham number
210.65
-
247.63
17.55%
258.80
4.51%
269.00
3.94%
349.38
29.88%
411.27
17.71%
358.34
12.87%
624.57
74.30%
1.04K
66.78%
535.24
48.62%
income quality
2.72
-
0.21
92.14%
0.90
318.77%
1.06
18.80%
0.80
24.37%
0.79
1.49%
1.44
81.70%
1.20
17.00%
0.48
59.94%
-1.02
312.29%
intangibles to total assets
0.00
-
0.00
21.90%
0.00
7.65%
0.00
21.80%
0.00
56.96%
0.00
11.30%
0.01
112.77%
0.04
695.71%
0.03
30.43%
0.04
26.23%
interest coverage
35.49
-
52.88
49.01%
65.90
24.62%
81.48
23.64%
140.15
72.00%
236.52
68.77%
147.45
37.66%
196.88
33.52%
442.96
124.99%
113.07
74.47%
interest debt per share
33.85
-
28.87
14.72%
25.30
12.38%
38.51
52.23%
46.88
21.74%
46.71
0.35%
71.21
52.44%
146.88
106.26%
146.66
0.15%
183.77
25.30%
inventory turnover
1.14
-
0.90
21.63%
0.88
1.91%
0.74
15.79%
0.68
8.32%
0.72
6.06%
0.89
23.87%
0.58
35.40%
0.71
24.01%
0.48
32.85%
invested capital
0.17
-
0.14
20.07%
0.12
14.80%
0.18
48.64%
0.21
21.01%
0.19
12.01%
0.27
44.75%
0.47
74.43%
0.36
24.57%
0.44
22.88%
market cap
75.31B
-
80.00B
6.22%
81.69B
2.12%
78.03B
4.48%
188.76B
141.90%
195.79B
3.72%
290.33B
48.29%
442.81B
52.52%
279.24B
36.94%
175.65B
37.10%
net current asset value
8.49B
-
9.37B
10.37%
10.08B
7.60%
11.52B
14.22%
12.46B
8.16%
15.72B
26.23%
13.14B
16.40%
13.31B
1.29%
16.14B
21.23%
5.28B
67.30%
net debt to ebitda
1.13
-
0.70
38.44%
0.33
52.12%
-0.17
150.92%
0.17
202.53%
-0.33
288.41%
-0.47
42.12%
-0.78
67.15%
-0.56
28.02%
1.27
326.77%
net income per share
10.20
-
13.21
29.56%
14.03
6.19%
14.74
5.05%
24.68
67.46%
30.17
22.24%
21.72
28.00%
55.80
156.87%
117.26
110.15%
30.34
74.12%
operating cash flow per share
35.92
-
3.92
89.09%
17.26
340.44%
20.97
21.50%
25.19
20.09%
31.71
25.91%
39.96
26.02%
83.72
109.49%
75.08
10.32%
-44.25
158.93%
payables turnover
8.38
-
10.75
28.27%
8.25
23.30%
8.18
0.74%
10.48
27.98%
11.21
6.98%
11.64
3.83%
2.66
77.10%
7.90
196.54%
5.69
28.04%
receivables turnover
3.44
-
3.00
12.83%
2.91
2.99%
3.10
6.73%
2.71
12.71%
2.62
3.27%
3.11
18.51%
3.68
18.35%
3.28
10.85%
3.08
5.92%
research and ddevelopement to revenue
return on tangible assets
0.04
-
0.05
27.35%
0.05
2.59%
0.05
1.09%
0.08
56.30%
0.09
9.25%
0.06
35.66%
0.10
73.31%
0.15
57.69%
0.04
73.18%
revenue per share
123.57
-
132.38
7.13%
136.72
3.28%
143.06
4.64%
165.56
15.73%
188.08
13.60%
201.01
6.87%
243.57
21.17%
412.88
69.51%
276.27
33.09%
roe
0.05
-
0.06
21.47%
0.07
3.23%
0.07
2.14%
0.11
66.24%
0.12
7.84%
0.08
31.71%
0.18
117.19%
0.29
58.77%
0.07
74.64%
roic
0.04
-
0.05
18.01%
0.05
7.31%
0.05
5.83%
0.09
66.41%
0.10
14.78%
0.06
39.59%
0.12
89.13%
0.22
85.48%
0.05
78.52%
sales general and administrative to revenue
shareholders equity per share
193.39
-
206.27
6.66%
212.17
2.86%
218.20
2.84%
219.81
0.74%
249.17
13.36%
262.72
5.44%
310.72
18.27%
411.26
32.36%
419.61
2.03%
stock based compensation to revenue
0.00
-
0.00
10.60%
0.00
14.79%
0.01
66.29%
0.01
13.58%
0.00
29.87%
0.00
30.04%
0.01
45.38%
tangible asset value
24.49B
-
26.19B
6.96%
26.98B
3.01%
27.52B
2.00%
27.41B
0.38%
30.76B
12.20%
32.31B
5.05%
35.32B
9.30%
48.13B
36.25%
48.76B
1.32%
tangible book value per share
193.39
-
206.27
6.66%
212.18
2.86%
218.21
2.84%
221.30
1.41%
250.71
13.29%
264.25
5.40%
285.96
8.21%
388.99
36.03%
392.25
0.84%
working capital
11.71B
-
12.06B
2.97%
12.30B
2.02%
15.61B
26.90%
16.22B
3.93%
18.68B
15.18%
17.91B
4.15%
19.52B
8.98%
20.13B
3.16%
12.04B
40.20%

All numbers in (except ratios and percentages)